Bombay Super Hybrid Seeds Ltd – Q3 Results Report
Value pick Multibagger Stock for long term investment
bombaysuperseeds.com NSE: BSHSL
Investment Highlights
Key Milestones
- Product Portfolio: From 30 to over 120 products (2018-2023)
- Infrastructure: 3,00,000 sq. ft. world-class R&D facilities
- Fully automated seed processing unit
Business Overview
Bombay Super Hybrid Seeds Ltd (BSHSL) operates in India’s agricultural sector with a strong focus on edible oilseeds like groundnut and sesame. Founded by Mr. Arvindkumar J. Kakadia, BSHSL has expanded to cover 14 major states with a depot presence in 8 states and a growing international footprint.
Growth Drivers
Aggressive R&D Expansion
- ₹1 Cr investment in breeding high-yield varieties
- Collaborations with ICRISAT, CIMMYT, IARI
- Focus on biofortified crops and climate-resilient seeds
Revenue Growth Trajectory
- Revenue CAGR ~25%: ₹3,000 Cr (FY25) to ₹6,200 Cr (FY28)
- Consistent 3-year sales growth of 14.5%
Technological Innovation
Advanced Technologies
- Buhler’s advanced sorting technology
- Eco-friendly seed cold storage (10,000 metric tons)
Crop Diversification
- Groundnut: Core contributor (~55% revenue)
- Growing contributions from cumin, gram, soybean
- Recent entry in hybrid maize, paddy, exotic vegetables
Financial Highlights
Product-Wise Revenue Contribution (H1FY24)
Product | Contribution |
---|---|
Groundnut Seeds | 54.7% |
Gram | 11.88% |
Wheat | 4.88% |
Soybean | 2.77% |
Cumin | 6.89% |
Other Agricultural Products | 16.49% |
Historical Financial Performance
Financial Year | Revenue (₹ Cr) | PAT (₹ Cr) | EBITDA Margin (%) |
---|---|---|---|
2019 | 77.08 | 2.08 | 6.26 |
2020 | 103.48 | 2.66 | 6.09 |
2023 | 227.91 | 16.78 | 9.71 |
H1FY24 | 150.42 | 12.21 | 10.51 |
Strategic Capital Expenditure
The planned ₹1 Cr R&D expenditure focuses on:
- High-Yield Varieties: Pearl millet with improved disease resistance
- Niche Products: Anti-cancer Korean cabbage and biofortified crops
- Exotic Crops: Screening of exotic germplasm in vegetables and flowers
These initiatives align with the company’s strategy to innovate in high-margin, health-focused seed products and meet emerging market demands.
Competitive Landscape
Strengths
- Extensive product portfolio
- Strong market penetration
- Global research partnerships
- High ROE (33%)
- Low debt-to-equity ratio
Weaknesses
- High stock valuation (P/E 58.9)
- Limited direct shareholder returns
- Zero dividend yield
Threats
- Vulnerability to monsoon patterns
- Competition from domestic players
- Pressure from global MNCs
Valuation Estimate
Using a forward P/E of 40x and FY25 estimated PAT of ₹80 Cr, we arrive at a target price of ₹152. While growth remains strong, the current valuation suggests limited upside in the near term.
Investment Thesis
Bombay Super Hybrid Seeds Ltd is well-positioned for sustained growth, driven by its robust R&D capabilities, diversified portfolio, and expanding geographical footprint. While its high valuation and dependency on monsoon conditions pose risks, long-term investors seeking exposure to India’s agritech sector may find value in its growth story.
Geographic Expansion
- Strengthened distribution network covering 14 Indian states
- Increasing export presence backed by international trade licenses
- Participation in global seed trade events
Balance Sheet Highlights
Debt Management
Significantly reduced from previous years
Equity Position
Showcasing strong equity growth
Disclaimer
This report is for informational purposes only and does not constitute financial advice. Investors are advised to conduct their own research or consult a financial advisor before making investment decisions.
Leave a Reply
You must be logged in to post a comment.